Solbritt Rantapää Dahlqvist
Solbritt Rantapää Dahlqvist is a Professor of Rheumatology at the University of Umeå. She holds a Ph.D. and a MD from the University of Umeå. Professor Rantapää Dahlqvist has been a Research Fellow at UCSF, San Francisco 1996-1997.
Her work has been published in a number of leading academic journals, including Annals of Rheumatic Diseases, Arthritis & Rheumatism, Nature Genetics and New England Journal of Medicine.
Professor Rantapää Dahlqvist’s research is patient related and focus on analysing aetio-patogenetic factors of importance for development of an inflammatory disease e.g. rheumatoid arthritis, and systemic lupus erythematosus, and for disease severity and development of co-morbidities, in particular cardio-vascular disease.
Her group was the first to publish that citrullinated antibodies preceded the onset of symptoms by several years. The relative risk was proved to be further increased by the presence of certain genes (HLA-shared epitope and PTPN22). Development of cardiovascular disease in early RA was predicted both by the inflammation but also by traditional risk factors. In patients who later developed SLE presence of particularly anti-nuclear antibodies, anti-SSA and anti double stranded DNA antibodies preceded onset by several years in a time dependent pattern.